Neuroectodermal Tumors: Clinical Trials

6 trials for Neuroectodermal Tumors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Terminated 6

Follow Neuroectodermal Tumors: new trials by email Literature Review of Neuroectodermal Tumors trials Research Report on Neuroectodermal Tumors

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Anticonvulsant Agent, Perampanel, Quality-of-Life Assessment - Intractable Epilepsy, Malignant Glioma
Phase 4TerminatedMayo Clinic42020-12-042023-06-22
Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies
immune-checkpoint inhibitors therapies - Advanced or Metastatic Melanoma, Advanced or Metastatic NSCLC
Phase 4TerminatedInstitut Paoli-Calmettes402019-10-162026-01-22
Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation
Sandostatin - Neuroendocrine Tumors, Carcinoid Syndrome
Phase 4TerminatedCliniques universitaires Saint-Luc- Université Catholique de Louvain102016-02-022019-10-25
HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
High Dose Interleukin-2, Ipilimumab - Metastatic Melanoma
Phase 4TerminatedClinigen, Inc.292013-05-012023-12-05
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
NovoTTF-100A - Recurrent Glioblastoma Multiforme
Phase 4TerminatedNovoCure Ltd.132012-12-012016-03-02
HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
vemurafenib + HD IL-2 - Metastatic Melanoma
Phase 4TerminatedClinigen, Inc.532012-08-012021-02-01

Narrower conditions

Melanoma (3)  ·  Skin Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Drug Resistant Epilepsy (1)  ·  Epilepsy (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Neoplasm Metastasis (1)  ·  Neuroendocrine Tumors (1)  ·  Recurrence (1)  ·  Serotonin Syndrome (1)

Broader conditions

Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Neoplasms, Nerve Tissue (6)  ·  Neoplasms by Site (4)  ·  Neuroendocrine Tumors (3)  ·  Nevi and Melanomas (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Nervous System Diseases (2)

Interventions

aldesleukin (2)  ·  Anticonvulsants (1)  ·  Interleukin-2 (1)  ·  Interleukins (1)  ·  Ipilimumab (1)  ·  Octreotide (1)  ·  Vemurafenib (1)  ·  perampanel (1)

Sponsors

Clinigen, Inc. (2)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Institut Paoli-Calmettes (1)  ·  Mayo Clinic (1)  ·  NovoCure Ltd. (1)

Countries

United States (4)  ·  France (1)

Top investigators

Herbert Engelhard, MD, PhD (1)  ·  Ivan Borbath, Prof (1)  ·  James Lowder, MD (1)  ·  Renaud Sabatier, MD (1)  ·  Sapna Patel, MD (1)  ·  Tharak Rao, MD (1)  ·  William Sharfman, MD (1)  ·  William Tatum (1)

Results publications

PMID 30053905, PMID 36239858

NIH funding

2018 (1)